Advisory Services Network, LLC

Position in EXEL — Exelixis, Inc.

CIK 1573876 Atlanta, GA

Position in EXEL

as of Mar 31, 2026 · filed May 15, 2026 Compact

Position Value

$1,262,766

+$257,219 QoQ

Shares Held

29,442

+28.3% QoQ

Ownership

0.012%

of shares outstanding

% of Portfolio

0.03%

of 13F equity value

Holder Rank

—

not a current holder

Holding Since

Mar 2020

12 quarters on record

Voting authority Sole 100.ToString("F0")% Shared 0.ToString("F0")% None 0.ToString("F0")%

Healthcare · as of Mar 31, 2026

Advisory Services Network, LLC holds $24,652,024 across 161 Biotechnology names. EXEL ranks #6 (5.1% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	INCY	Incyte Corp	51,990	$4,893,296
2	REGN	Regeneron Pharmaceuticals, Inc.	3,953	$3,054,242
3	VRTX	Vertex Pharmaceuticals Inc / Ma	5,218	$2,330,040
4	ALNY	Alnylam Pharmaceuticals, Inc.	6,314	$2,089,107
5	RPRX	Royalty Pharma plc	33,855	$1,624,023
6	EXEL	Exelixis, Inc. This page	29,442	$1,262,766
7	OCUL	Ocular Therapeutix, Inc	138,897	$1,176,456
8	WVE	Wave Life Sciences Ltd.	144,950	$1,050,887

12 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-03-31	$1,262,766	29,442	+28.3%	Shares	Sole	2026-05-15
2025-12-31	$1,005,547	22,942	-51.2%	Shares	Sole	2026-02-17
2025-09-30	$1,942,875	47,043	+15.6%	Shares	Sole	2025-11-18
2025-06-30	$1,793,967	40,698	+38.6%	Shares	Sole	2025-08-19
2025-03-31	$1,084,117	29,364	+432.2%	Shares	Sole	2025-05-15
2023-12-31	$132,352	5,517	+174.6%	Shares	Sole	2024-02-09
2023-03-31	$38,994	2,009	+5.2%	Shares	Sole	2023-05-17
2022-12-31	$30,620	1,909	-19.1%	Shares	Sole	2023-02-13
2021-06-30	$42,999	2,360	0.0%	Shares	Sole	2021-08-12
2020-12-31	$47,365	2,360	+164.0%	Shares	Sole	2021-02-09
2020-09-30	$21,858	894	+17.6%	Shares	Sole	2020-11-16
2020-03-31	$13,087	760	—	Shares	Sole	2020-05-15
No filing history on record for this holder in this stock.